FI915210L - Foerlaekemedel foer b-laktamas och deras anvaendning. - Google Patents

Foerlaekemedel foer b-laktamas och deras anvaendning. Download PDF

Info

Publication number
FI915210L
FI915210L FI915210A FI915210A FI915210L FI 915210 L FI915210 L FI 915210L FI 915210 A FI915210 A FI 915210A FI 915210 A FI915210 A FI 915210A FI 915210 L FI915210 L FI 915210L
Authority
FI
Finland
Prior art keywords
laktamas
foerlaekemedel
foer
och deras
deras anvaendning
Prior art date
Application number
FI915210A
Other languages
English (en)
Finnish (fi)
Other versions
FI915210A0 (fi
FI915210A7 (fi
Inventor
John Kadow
Takushi Kaneko
Peter D Senter
Vivekananda M Vrudhula
Original Assignee
Bristol Myers Squibb Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Squibb Co filed Critical Bristol Myers Squibb Co
Publication of FI915210A0 publication Critical patent/FI915210A0/fi
Publication of FI915210A7 publication Critical patent/FI915210A7/fi
Publication of FI915210L publication Critical patent/FI915210L/fi

Links

Classifications

    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/54—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
    • A61K47/55—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound the modifying agent being also a pharmacologically or therapeutically active agent, i.e. the entire conjugate being a codrug
    • A61K47/552—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound the modifying agent being also a pharmacologically or therapeutically active agent, i.e. the entire conjugate being a codrug one of the codrug's components being an antibiotic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/54—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
    • A61K47/555—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound pre-targeting systems involving an organic compound, other than a peptide, protein or antibody, for targeting specific cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/68—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
    • A61K47/6891—Pre-targeting systems involving an antibody for targeting specific cells
    • A61K47/6899—Antibody-Directed Enzyme Prodrug Therapy [ADEPT]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nanotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Medical Informatics (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Cephalosporin Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
FI915210A 1990-11-06 1991-11-05 Foerlaekemedel foer b-laktamas och deras anvaendning. FI915210L (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US60966390A 1990-11-06 1990-11-06
US77037191A 1991-10-08 1991-10-08

Publications (3)

Publication Number Publication Date
FI915210A0 FI915210A0 (fi) 1991-11-05
FI915210A7 FI915210A7 (fi) 1992-05-07
FI915210L true FI915210L (fi) 1992-05-07

Family

ID=27086090

Family Applications (1)

Application Number Title Priority Date Filing Date
FI915210A FI915210L (fi) 1990-11-06 1991-11-05 Foerlaekemedel foer b-laktamas och deras anvaendning.

Country Status (8)

Country Link
EP (2) EP0484870A3 (fr)
JP (1) JPH04264089A (fr)
AU (1) AU649275B2 (fr)
CA (1) CA2055062A1 (fr)
FI (1) FI915210L (fr)
IE (1) IE913862A1 (fr)
MX (1) MX9101956A (fr)
ZA (1) ZA918738B (fr)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1994001137A1 (fr) * 1992-07-06 1994-01-20 Hybritech Incorporated Procede d'aministration d'agents cytotoxiques et constituants de ceux-ci
GB9216759D0 (en) * 1992-08-07 1992-09-23 Finpael Spa Process for the production of 7-amino thiazolyl cephalosporins
DE4236237A1 (de) * 1992-10-27 1994-04-28 Behringwerke Ag Prodrugs, ihre Herstellung und Verwendung als Arzneimittel
GB9314562D0 (en) * 1993-07-14 1993-08-25 Erba Carlo Spa Use of cephem derivatives as anti-metastatic agents
WO1995020567A1 (fr) * 1994-01-28 1995-08-03 University Of Kentucky Research Foundation Co-medicaments utilises comme procede d'apport regule de medicaments
CA2177644A1 (fr) * 1995-05-31 1996-12-01 Peter D. Senter Promedicaments polymeriques pour la beta-lactamase et leur utilisation
JP2002510968A (ja) * 1997-05-07 2002-04-09 ブリストル−マイヤーズ スクイブ カンパニー 組換え抗体−酵素融合タンパク質
US6159706A (en) * 1997-12-23 2000-12-12 Newbiotics, Inc. Application of enzyme prodrugs as anti-infective agents
WO2000020608A1 (fr) * 1998-10-02 2000-04-13 Genotherapeutics, Inc. Procede de traitement du cancer de la prostate au moyen d'un vecteur d'expression adenoviral codant pour une enzyme de promedicament
WO2001053355A1 (fr) * 2000-01-24 2001-07-26 The Trustees Of Columbia University In The City Of New York Crible in vivo mettant en application des inducteurs chimiques de dimerisation
WO2001083492A1 (fr) * 2000-05-02 2001-11-08 Newbiotics, Inc. Antibiotiques de la famille des beta-lactamines ameliores
AU2001293555A1 (en) * 2000-09-21 2002-04-02 Novation Pharmaceuticals Inc. Benzoic acid derivatives and uses thereof
US7083918B2 (en) 2002-04-24 2006-08-01 The Trustees Of Columbia University In The City Of New York Bacterial small-molecule three-hybrid system
US7767792B2 (en) 2004-02-20 2010-08-03 Ludwig Institute For Cancer Research Ltd. Antibodies to EGF receptor epitope peptides
EP1735350B1 (fr) * 2004-04-15 2010-08-25 Genencor International, Inc. Construits anti-cea scfv-beta lactamase (molecules cab) pour adept
CN108338982A (zh) * 2017-12-27 2018-07-31 天津国际生物医药联合研究院 头孢噻吩钠在抗白血病的药物中的应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1509707A (en) * 1974-09-20 1978-05-04 Searle & Co Immunological compounds
NZ225599A (en) * 1987-08-04 1991-09-25 Bristol Myers Co Antibody-enzyme conjugates and combinations with prodrugs for the treatment of tumour cells
AU633867B2 (en) * 1989-02-02 1993-02-11 Eli Lilly And Company Delivery of cytotoxic agents
GB8907617D0 (en) * 1989-04-05 1989-05-17 Celltech Ltd Drug delivery system

Also Published As

Publication number Publication date
ZA918738B (en) 1992-07-29
AU8687991A (en) 1993-04-01
FI915210A0 (fi) 1991-11-05
AU649275B2 (en) 1994-05-19
JPH04264089A (ja) 1992-09-18
EP0484870A2 (fr) 1992-05-13
FI915210A7 (fi) 1992-05-07
MX9101956A (es) 1992-07-08
EP0742015A1 (fr) 1996-11-13
IE913862A1 (en) 1992-05-22
CA2055062A1 (fr) 1992-05-07
EP0484870A3 (en) 1992-09-02

Similar Documents

Publication Publication Date Title
FI900494A0 (fi) Anordning foer ingaongs- och utgaongsluft och luftkonditioneringsfoerfarande.
FI915210L (fi) Foerlaekemedel foer b-laktamas och deras anvaendning.
FI904071A7 (fi) Supraledande foerbindning foer tunnskiktskomponenter och foerfarande foer deras framstaellning.
FI904369L (fi) Belaeggning och belaeggningsfoerfarande foer en aongturbin och daertill anslutna staolytor.
FI904014A0 (fi) Fastklibbande materialer och deras framstaellning.
FI902014A0 (fi) Foerfarande och anordning foer skjutoevning.
FI903615A0 (fi) Borrningsfoerfarande och borrkroneapparatur.
FI900479A7 (fi) Foerfarande och anordning foer predikterande kodning.
FI83361B (fi) Fogkonstruktion och foerstycke.
FI903825A7 (fi) Trappsteg och foerfarande foer tillverkning daerav.
FI902670A0 (fi) Gasblandning och excimerlaser foer anvaendning daerav.
FI904367A0 (fi) Kommuniceringsfoerfarande och media-apparat foer visuell kommunikation.
FI904241A7 (fi) Anordning foer byggnadsavfall och avfallscontainer.
FI904373A0 (fi) Gasavskiljare foer vaetskor och suspensioner.
FI904031A7 (fi) Hoernbalk och fogkonstruktion foer byggnad.
FI904440A0 (fi) Saerskilt foer raffinoerer avsedd malskiva och motsvarande raffinoer.
FI904502A0 (fi) Skyddstygsprodukt och foerfarande foer framstaellning daerav.
FI903267A0 (fi) Elapparat och daerfoer avsett jordningsorgan.
FI902888A0 (fi) Enzymprodukt och foerfarande foer framstaellning daerav.
FI902786A7 (fi) Reparationsfoerpackning och tillaeggsreflex.
FI902015L (fi) Foerfarande och anordning foer skjutoevning.
FI904530A0 (fi) Nedtryckningsarrangemang foer traktormaskin och arbetsmaskin.
FI901805A0 (fi) Vaextbassaengsystem och delar daertill.
FI901720A0 (fi) Anordning foer kvistning och roejning.
FI901637A7 (fi) Andningsapparat foer giftgas och roekdykning.